In the present study, we investigated the plasma concentrations of CXCL1 and CXCL8 in female breast cancer patients as potential tumor markers in the diagnostic process, as an individual or combined parameter with the routinely used marker CA 15-3. This evidence concerns the gene CXCL1 and neoplasm.